Madrigal Prescribed drugs, Inc. (MDGL) Presents at forty fourth Annual J.P. Morgan Healthcare Convention Transcript

Pradyumna Raveesh

Good afternoon, everybody, and welcome. I am Pradyumna from JPMorgan’s healthcare staff. Thanks for becoming a member of us for the decision Madrigal Prescribed drugs presentation right now. Madrigal has been probably the most consequential firms within the metabolic and liver illness over the previous couple of years. And right now, we’re happy to be joined by Invoice Sibold, the Chief Govt Officer; Dr. David Soergel, Chief Medical Officer; and Mardi Dier, the Chief Monetary Officer.

Invoice and David will converse for about 20 minutes, after which we’ll transfer right into a reside Q&A session. At that time, we’ll even be joined by Mardi Dier. With that, Invoice, I will flip it over to you.

William Sibold
CEO, President & Director

Thanks, Prad, and thanks to JPMorgan for having us right here. That is all the time an effective way to kick off the yr and to offer a progress replace for a way we’re doing. I will begin by saying that that is an thrilling time at Madrigal. You have typically heard me say that I feel that is the perfect alternative within the trade. All the things that we have completed within the final 12 months, 24 months and searching forward, I firmly imagine that greater than I did after I began on this function in September of 2023.

On the slide right here, main the battle towards MASH, that’s our function assertion. You do not have to look a lot additional than that to grasp what we’re about. We’re about MASH. We’re about management, and we predict we’ve got to carry just a little little bit of an edge to this to really